A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...
Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...
Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Eli Lilly's surging GLP-1 momentum and Johnson & Johnson's diversified strength set up a compelling 2025 showdown for ...
The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.
Older age in adults with diabetic macular edema (DME) appears to be associated with less robust visual and anatomic gains from anti-vascular endothelial growth factor (VEGF) therapy, according to ...